What's On

Bio Connections Australia

09:00 AM - Tuesday 13 November, 2018
Australia is well positioned to be a leading destination for early phase clinical trials, commencing over 1000 new trials each year. But how can we, and the rest of the world, further capitalise on this opportunity?

Bio Connections Australia is a brand new event designed to foster the growth of early phase clinical research in Australia. As a unique platform for networking and discussion, the conference will explore drug development, early phase clinical trials, translational research and expediting Australia’s great science into commercialisation.

Bringing together a mix of the nation’s industry executives, researchers, and academics, the two-day event will also be attended by international pharmaceutical and biotechnology companies looking to conduct clinical trial activity in Australia.

Location: Pullman on the Park, Melbourne.  Register HereAgenda Here.

Conference agenda topics & features:
  • The opportunities and obstacles to early phase clinical trials in Australia vs International
  • Aussie biotech success stories & the path to commercial success
  • Optimising drug development in Australia
  • Global best practice tools & techniques for designing a clinical development programme
  • Leveraging Emerging Technologies Including Machine Learning & Deep Sequencing for Clinical Development
  • Medical device trials in Australia
  • Assessing partnerships in clinical trials
  • Translational research and expediting research into commercialization
  • Models for turning discovery into drugs
  • Finding the funding – navigating challenges and getting ahead of the pack
  • Government incentives for biotech, pharma and medtech companies in Australia
  • Recruitment and engagement in clinical trials across Australia
  • Mitigating risk and ensuring patient safety
  • Australia as a springboard into Asia – regional partnership opportunities
  • The regulatory environment in Australia & comparing international regulatory pathways
  • Governance, bureaucracy, ethics: How we cultivate innovation rather than stifling it
  • Driving greater collaboration across academia and industry